학술논문
A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapy
Document Type
Article
Author
Source
In Radiotherapy and Oncology December 2019 141:101-107
Subject
Language
ISSN
0167-8140